Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 34Esophageal Neoplasms 19Pancreatic Neoplasms 9Esophageal Squamous Cell Carcinoma 6Stomach Neoplasms 4Colorectal Neoplasms 4Carcinoma, Squamous Cell 3Resectable Esophageal Cancer 2Pathologic Complete Response 2Neoplasms by Site 2Neoplasms 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Carcinoma 2Adenocarcinoma Of Esophagus 2Adenocarcinoma 2Thrombocytopenia 1Rectal Malignant Neoplasms 1Rectal Diseases 1Radiation Injuries 1Postoperative Complications 1Patients With Esophageal Cancer(â…¡-â…¢) 1Pancreatic Cancer Non-resectable 1Neoplasms, Glandular and Epithelial 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasms by Histologic Type 1Margins of Excision 1Lymphatic Metastasis 1Low Anterior Resection Syndrome 1Locally Advanced Rectal Cancer 1

Interventions

camrelizumab 4Oxaliplatin 3apatinib 2S 1 (combination) 2Capecitabine 2XELOX 1Taxes 1Surgical Procedures, Operative 1Nivolumab 1Laparoscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Gastrectomy 1Conversion to Open Surgery 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Gastric Cancer × Chemoradiotherapy × Gastrointestinal × Clear all
NCT05528367 2022-09-06

Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Zhejiang Cancer Hospital

Phase 2 Unknown
33 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡